Adequate exposure to tacrolimus with sublingual administration in pediatric liver transplant patients

Int J Clin Pharmacol Ther. 2017 Apr;55(4):352-354. doi: 10.5414/CP202719.
No abstract available

Publication types

  • Letter
  • Observational Study

MeSH terms

  • Administration, Sublingual
  • Age Factors
  • Biliary Atresia / surgery*
  • Calcineurin Inhibitors / administration & dosage*
  • Calcineurin Inhibitors / blood
  • Calcineurin Inhibitors / pharmacokinetics
  • Child
  • Child, Preschool
  • Drug Monitoring / methods
  • Female
  • Graft Rejection / immunology
  • Graft Rejection / prevention & control
  • Graft Survival / drug effects
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Immunosuppressive Agents / blood
  • Immunosuppressive Agents / pharmacokinetics
  • Infant
  • Liver Transplantation* / adverse effects
  • Male
  • Retrospective Studies
  • Tacrolimus / administration & dosage*
  • Tacrolimus / blood
  • Tacrolimus / pharmacokinetics
  • Treatment Outcome

Substances

  • Calcineurin Inhibitors
  • Immunosuppressive Agents
  • Tacrolimus